Lymphovascular Invasion Is Associated With Doxorubicin Resistance in Breast Cancer

被引:0
|
作者
Corachea, Allen Joy M. [1 ]
Ferrer, Regina Joyce E. [1 ]
Ty, Lance Patrick B. [1 ]
Aquino, Lizzie Anne C. [2 ]
Morta, Madeleine T. [1 ]
Macalindong, Shiela S. [2 ]
Uy, Gemma Leonora B. [2 ]
Odono, Eugene G. [3 ]
Llames, Jo-Hannah S. [4 ]
Tablizo, Francis A. [4 ]
Paz, Eva Maria C. Cutiongco-Dela [5 ]
Dofitas, Rodney B. [2 ]
Velarde, Michael C. [1 ]
机构
[1] Univ Philippines Diliman, Inst Biol, Coll Sci, Quezon City, Philippines
[2] Univ Philippines Manila, Philippine Gen Hosp, Dept Surg, Manila, Philippines
[3] Univ Philippines Manila, Philippine Gen Hosp, Dept Pathol, Manila, Philippines
[4] Univ Philippines, Philippine Genome Ctr, Quezon City, Philippines
[5] Univ Philippines Manila, NIH, Manila, Philippines
关键词
breast cancer; lymphovascular invasion; drug resistance; patient-derived organoids; SURGICAL ADJUVANT BREAST; NEOADJUVANT TREATMENT; ENRICHMENT ANALYSIS; CYP1B1; INHIBITORS; DOCETAXEL; DISEASE; MODELS;
D O I
10.1016/j.labinv.2025.104115
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lymphovascular invasion (LVI), the invasion of tumor cells into the lymphatic or vascular space, is an early indicator of potential metastasis, with its presence in breast cancer independently predicting poorer outcomes even after neoadjuvant chemotherapy. However, a major limitation is that LVI detection currently relies on postsurgical evaluation. To address this, we determined whether LVI+ breast tumors contain a unique gene signature that could facilitate earlier detection. Here, we conducted an integrative analysis of the gene profile between LVI+ and LVI- primary breast tumors from various sources, including published data and our own research, using both microarray and RNA-seq data. Our analysis revealed protein binding and vesicle-related genes to be the most enriched categories in LVI+ vs LVI- tumors. Furthermore, LVI+ tumors showed enrichment for xenobiotic metabolism genes, particularly drug metabolism enzymes, such as cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases. An elastic net regression model containing 13 of these uridine 5'-diphospho-glucuronosyltransferases and cytochrome P450 genes can predict LVI status with 92% accuracy. This suggests a potential link to drug resistance, which was further confirmed by the finding that patients with LVI+ tumors had a significantly lower clinical response rate than individuals with LVI- tumors. We also observed this resistance in patient-derived organoids, with LVI+ organoids exhibiting lower sensitivity to doxorubicin, implying that doxorubicin might be less effective for LVI+ breast cancer, potentially contributing to poorer outcomes. Overall, our study unlocked an exciting opportunity for personalized medicine, in that, therapy efficacy and patient outcomes can be improved by incorporating the LVI-associated gene signature into treatment plans. (c) 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Prognostic Role of Lymphovascular Invasion in Patients with Early Breast Cancer
    Akrami, M.
    Meshksar, A.
    Ghoddusi, Johari M.
    Safarpour, M. M.
    Tahmasebi, S.
    Zangouri, V.
    Talei, A.
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2021, 12 (04) : 671 - 677
  • [22] Prognostic Role of Lymphovascular Invasion in Patients with Early Breast Cancer
    M. Akrami
    A. Meshksar
    Johari M. Ghoddusi
    M. M. Safarpour
    S. Tahmasebi
    V. Zangouri
    A. Talei
    Indian Journal of Surgical Oncology, 2021, 12 : 671 - 677
  • [23] Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer
    Schoppmann, SF
    Bayer, G
    Aumayr, K
    Taucher, S
    Geleff, S
    Rudas, M
    Kubista, E
    Hausmaninger, H
    Samonigg, H
    Gnant, M
    Jakesz, R
    Horvat, R
    ANNALS OF SURGERY, 2004, 240 (02) : 306 - 312
  • [24] Breast cancer specific survival by node status and lymphovascular invasion
    Karanikolic, A.
    Djordjevic, N.
    Budjevac, D.
    Djordjevic, L.
    Paravina, J.
    EJC SUPPLEMENTS, 2008, 6 (07): : 181 - 181
  • [25] Lymphovascular invasion, as a prognostic marker in patients with invasive breast cancer
    Gurleyik, G.
    Gurleyik, E.
    Aker, F.
    Aktekin, A.
    Emir, S.
    Gungor, O.
    Saglam, A.
    ACTA CHIRURGICA BELGICA, 2007, 107 (03) : 284 - 287
  • [26] The Presence of Extensive Lymphovascular Invasion is Associated With Higher Risks of Local-Regional Recurrence Compared With Usual Lymphovascular Invasion in Curatively Treated Breast Cancer Patients
    Koleoso, Olufela
    Toumbacaris, Nicolas
    Brogi, Edi
    Zhang, Zhigang
    Braunstein, Lior Z.
    Morrow, Monica
    Moo, Tracy-Ann
    El-Tamer, Mahmoud
    Marine, Catherine B.
    Powell, Simon N.
    Khan, Atif J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (03): : 835 - 844
  • [27] Prognostic Role of Lymphovascular Invasion and Perineural Invasion in Breast Cancer Treated with Neoadjuvant Chemotherapy
    Cavdar, Eyyup
    Iriagac, Yakup
    Karaboyun, Kubilay
    Avci, Okan
    Oznur, Meltem
    Seber, Erdogan Selcuk
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2022, 32 (03): : 141 - 149
  • [28] Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response
    Asaoka, Mariko
    Patnaik, Santosh K.
    Zhang, Frank
    Ishikawa, Takashi
    Takabe, Kazuaki
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (02) : 309 - 322
  • [29] LYMPHOVASCULAR INVASION IN OVARIAN CANCER
    Ouldamer, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A504 - A504
  • [30] Gene expression associated with lymphovascular invasion and genomic risk in early-stage breast cancer.
    D'Abreo, Nina
    Rohatgi, Abhinav
    Marks, Douglas Kanter
    Kling, Heather
    Haan, Josien
    Audeh, William
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)